Company Filing History:
Years Active: 2016
Title: Stefanie Krenzlin: Innovator in Pharmaceutical Composition
Introduction
Stefanie Krenzlin is a notable inventor based in Brandenburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release oral compositions. Her innovative work has the potential to enhance drug delivery systems and improve patient outcomes.
Latest Patents
Stefanie holds a patent for a "Modified starch derivative-based matrix for colon targeting." This invention involves a controlled-release oral pharmaceutical composition that includes a lipophilic matrix and a hydrophilic matrix. The hydrophilic matrix contains an indigestible polysaccharide, with the active ingredient dispersed within both matrices. This invention also outlines a process for preparing such a pharmaceutical composition, showcasing her expertise in the field.
Career Highlights
Stefanie Krenzlin is associated with Roquette Freres, a company known for its focus on innovative solutions in the food and pharmaceutical industries. Her work at Roquette Freres has allowed her to apply her knowledge and skills in developing advanced pharmaceutical formulations.
Collaborations
Stefanie has collaborated with notable colleagues, including Olaf Haeusler and Marie-Helene DeGrave. These collaborations have contributed to her success and the advancement of her research in pharmaceutical compositions.
Conclusion
Stefanie Krenzlin is a pioneering inventor whose work in pharmaceutical compositions is making a significant impact in the industry. Her innovative approach to drug delivery systems exemplifies the importance of research and development in improving healthcare solutions.